Skip to main content
Premium Trial:

Request an Annual Quote

Who Cares If They're Small? They're Sticky!

MIT, Harvard, and Massachusetts General Hospital have teamed up to commercialize a new diagnostic that uses magnetic nanoparticles to detect viruses and bacteria, reports MIT’s Technology Review. The company, T2 Biosystems, has developed particles that are coated with molecules like antibodies or DNA; when exposed to a magnetic field, the particles bind to their target and form clumps that can be easily visualized. The hope is that the particles will be able to identify viruses and infectious pathogens earlier, as well as help monitor cancer more easily.

The Scan

mRNA-Based Vaccine on the Way in China

China may soon have its own mRNA-based vaccine, according to Nature News.

Arranged Killing, Fraud Alleged by Prosecutors

The Wall Street Journal reports that prosecutors allege that the co-founder of a biotech arranged to have a business associate who threatened to expose him as a fraud killed.

Whirlwind Decade of CRISPR

The New York Times looks back at the 10 years since the University of California, Berkeley's Jennifer Doudna and her colleagues published their CRISPR paper.

PNAS Papers on Blue Cone Monochromacy Structural Variants, HIV-1 Mutant, T-ALL

In PNAS this week: structural variants linked to blue cone monochromacy, HIV-1 variants affecting the matrix protein p17, and more.